Literature DB >> 29304216

Hypertension Control in Adults With CKD in China: Baseline Results From the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).

Zhe Yan1, Yu Wang2, Shaomei Li1, Jinwei Wang2, Luxia Zhang2, Huibin Tan1, Sumin Li1, Lin Yang1, Huaying Pei1, Liping Zhang1, Yan Wang1, Jianzhao Duan1, Sumin Jiao1, Minghui Zhao2, Shuxia Fu1.   

Abstract

BACKGROUND: Hypertension contributes to increased morbidity and mortality in the chronic kidney disease (CKD) population. Studies on blood pressure control in CKD patients in China are limited. In this study, we aimed to describe the status of blood pressure control in Chinese CKD patients based on the first national prospective CKD cohort data.
METHODS: A subgroup of Chinese Cohort Study of Chronic Kidney Disease participants with hypertension at baseline was included in the present study. Uncontrolled blood pressure was defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg. Defined daily doses (DDDs) are used as a standard measurement of drug utilization in this population. Factors associated with uncontrolled blood pressure were analyzed using multivariable logistic regression.
RESULTS: There were 2,251 hypertensive CKD subjects among 2,873 predialysis CKD participants. The awareness, treatment, and control rates of hypertension were 80.7%, 95.6%, and 57.1%, respectively. Factors independently associated with uncontrolled blood pressure were overweight, obesity, albuminuria, decreased estimated glomerular filtration rate (eGFR), and diabetes. Over 50% of study subjects were prescribed 2 or more antihypertensive medications and only 7% were prescribed diuretics. Uncontrolled hypertensive patients were prescribed less antihypertensive medication than controlled hypertensives (DDD 1.3 [1.0-2.3] vs. 2.0 [1.0-3.1], P < 0.001).
CONCLUSIONS: Hypertension control was suboptimal among hypertensive CKD patients in China, especially among those overweight or with obesity, albuminuria, lower eGFR, and diabetes. Patients with uncontrolled hypertension should undergo treatment regimen evaluation to select the appropriate dosage and type of antihypertensive medications.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29304216     DOI: 10.1093/ajh/hpx222

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  12 in total

1.  China Kidney Disease Network (CK-NET) 2015 Annual Data Report.

Authors:  Luxia Zhang; Ming-Hui Zhao; Li Zuo; Yue Wang; Feng Yu; Hong Zhang; Haibo Wang
Journal:  Kidney Int Suppl (2011)       Date:  2019-02-20

Review 2.  Blood Pressure and Chronic Kidney Disease Progression: An Updated Review.

Authors:  Elmukhtar Habas; Eshrak Habas; Fahmi Y Khan; Amnna Rayani; Aml Habas; Mehdi Errayes; Khalifa L Farfar; Abdel-Naser Y Elzouki
Journal:  Cureus       Date:  2022-04-18

3.  Utilization of antihypertensive drugs among chronic kidney disease patients: Results from the Chinese cohort study of chronic kidney disease (C-STRIDE).

Authors:  Bianling Liu; Qin Wang; Yu Wang; Jinwei Wang; Luxia Zhang; Minghui Zhao
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-09       Impact factor: 3.738

Review 4.  Hypertension and chronic kidney disease in Asian populations.

Authors:  Boon Wee Teo; Gek Cher Chan; Christopher Cheang Han Leo; Jam Chin Tay; Yook-Chin Chia; Saulat Siddique; Yuda Turana; Chen-Huan Chen; Hao-Min Cheng; Satoshi Hoshide; Huynh Van Minh; Guru Prasad Sogunuru; Tzung-Dau Wang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-04       Impact factor: 3.738

5.  Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE).

Authors:  Qiongjing Yuan; Jinwei Wang; Zhangzhe Peng; Qiaoling Zhou; Xiangcheng Xiao; Yanyun Xie; Wei Wang; Ling Huang; Wenbin Tang; Danni Sun; Luxia Zhang; Fang Wang; Ming-Hui Zhao; Lijian Tao; Kevin He; Hui Xu
Journal:  J Transl Med       Date:  2019-03-15       Impact factor: 5.531

6.  Wnt/β-catenin/RAS signaling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction.

Authors:  Jinhua Miao; Jiafeng Liu; Jing Niu; Yunfang Zhang; Weiwei Shen; Congwei Luo; Yahong Liu; Chuanjiang Li; Hongyan Li; Peiliang Yang; Youhua Liu; Fan Fan Hou; Lili Zhou
Journal:  Aging Cell       Date:  2019-07-18       Impact factor: 9.304

7.  Effects of allisartan isoproxil on blood pressure and target organ injury in patients with mild to moderate essential hypertension.

Authors:  Jian-Qi Zhang; Guo-Hong Yang; Xin Zhou; Jun-Xiang Liu; Rui Shi; Yan Dong; Shao-Bo Chen; Yu-Ming Li
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

8.  Short-Term Systolic Blood Pressure Variability and Kidney Disease Progression in Patients With Chronic Kidney Disease: Results From C-STRIDE.

Authors:  Qin Wang; Yu Wang; Jinwei Wang; Luxia Zhang; Ming-Hui Zhao
Journal:  J Am Heart Assoc       Date:  2020-06-06       Impact factor: 5.501

Review 9.  The DASH Diet and Cardiometabolic Health and Chronic Kidney Disease: A Narrative Review of the Evidence in East Asian Countries.

Authors:  Yazhen Song; Andrea J Lobene; Yanfang Wang; Kathleen M Hill Gallant
Journal:  Nutrients       Date:  2021-03-18       Impact factor: 5.717

10.  The prevalence, relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai, China: a cross-section study : Prevalence of H type hypertension.

Authors:  Bin Hong; Zhao-Qiang Cui; Jun-Bo Ge; Xiao-Lin Qian; Hong Cao; Jun Zhang; Zhi-Hui Gu; Wei-Qin Tang; Lei Shen; Jia-Lu Hu; Zhi-Feng Yao; Lei Zhang; Min-Na Tang; Xu-Cheng Lv; Jun Zhou; Xue-Juan Jin
Journal:  BMC Cardiovasc Disord       Date:  2021-08-04       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.